To include your compound in the COVID-19 Resource Center, submit it here.

Spyryx starts Phase II for CF

Spyryx Biosciences Inc. (Durham, N.C.) began a Phase II trial evaluating SPX-101 in up to

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE